Compare NNVC & PRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NNVC | PRA |
|---|---|---|
| Founded | 2005 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.7M | 1.2B |
| IPO Year | N/A | N/A |
| Metric | NNVC | PRA |
|---|---|---|
| Price | $1.11 | $24.05 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $22.50 |
| AVG Volume (30 Days) | 341.7K | ★ 401.7K |
| Earning Date | 02-13-2026 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.66 |
| Revenue | N/A | ★ $1,120,385,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.24 |
| P/E Ratio | ★ N/A | $36.56 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.94 | $13.90 |
| 52 Week High | $2.23 | $24.41 |
| Indicator | NNVC | PRA |
|---|---|---|
| Relative Strength Index (RSI) | 38.64 | 49.13 |
| Support Level | $1.20 | $24.14 |
| Resistance Level | $1.31 | $24.16 |
| Average True Range (ATR) | 0.08 | 0.11 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 6.67 | 16.47 |
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in five segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, Lloyd's Syndicate, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.